معرفی
Gunnar Buyse serves as a full Professor in the Department of Development and Regeneration at KU Leuven's Faculty of Medicine, with clinical affiliation at UZ Leuven's Unit Locomotor and Neurological Disorders. He actively contributes to academic governance as a member of the Faculty of Medicine Council, Department Council, and Culture/Art Committee.
His research centers on pediatric neuromuscular disorders including Duchenne muscular dystrophy and muscle wasting conditions, alongside neurological conditions like genetic epilepsies and ophthalmoplegic neuropathy. He pioneers translational approaches using iPSC models, extracellular vesicles, and miRNA therapies to develop regenerative treatments, while also innovating non-invasive solutions such as digital pain management systems for children.
Analysis of his recent publications reveals three dominant research trajectories: molecular interventions targeting muscle regeneration through extracellular vesicles and miRNAs; development of pediatric neuroimaging preparation tools using smartphone technology; and genetic investigations of rare neurodevelopmental disorders including Dandy-Walker malformation and FHF1-related encephalopathy. His work consistently bridges basic science with clinical applications for childhood neurological conditions.
Professor Buyse secures substantial research funding as co-promotor for major projects including 'Little NIRVANA 2.0' (2023-2026) developing digital pain management for children and 'Unlocking Therapeutic Potential' (2020-2024) exploring extracellular vesicles for muscle wasting disorders. He supervises doctoral candidates, notably co-guiding L. Yedigaryan's 2024 thesis on vesicle-based therapies.
He leads a multidisciplinary research team at KU Leuven integrating clinical neurology, molecular biology, and regenerative medicine approaches to address locomotor and neurological disorders in pediatric populations, with current work focusing on Duchenne cardiomyopathy mechanisms and pediatric pain management innovation.